DK3325490T3 - 1-substituerede 1,2,3,4-tetrahydro-1,7-naphthyridin-8-aminderivater og deres anvendelse som ep4-receptorantagonister - Google Patents
1-substituerede 1,2,3,4-tetrahydro-1,7-naphthyridin-8-aminderivater og deres anvendelse som ep4-receptorantagonister Download PDFInfo
- Publication number
- DK3325490T3 DK3325490T3 DK16753995.6T DK16753995T DK3325490T3 DK 3325490 T3 DK3325490 T3 DK 3325490T3 DK 16753995 T DK16753995 T DK 16753995T DK 3325490 T3 DK3325490 T3 DK 3325490T3
- Authority
- DK
- Denmark
- Prior art keywords
- naphthyridine
- tetrahydro
- substituted
- receptor antagonists
- amine derivatives
- Prior art date
Links
- -1 1-SUBSTITUTED 1,2,3,4-TETRAHYDRO-1,7-NAPHTHYRIDINE-8-AMINE Chemical class 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2244DE2015 | 2015-07-23 | ||
| PCT/JP2016/072244 WO2017014323A1 (en) | 2015-07-23 | 2016-07-22 | 1-substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as ep4 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3325490T3 true DK3325490T3 (da) | 2020-02-03 |
Family
ID=56740432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16753995.6T DK3325490T3 (da) | 2015-07-23 | 2016-07-22 | 1-substituerede 1,2,3,4-tetrahydro-1,7-naphthyridin-8-aminderivater og deres anvendelse som ep4-receptorantagonister |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10745397B2 (da) |
| EP (1) | EP3325490B1 (da) |
| JP (1) | JP6689297B2 (da) |
| CN (1) | CN108368127B (da) |
| CA (1) | CA2993312A1 (da) |
| DK (1) | DK3325490T3 (da) |
| WO (1) | WO2017014323A1 (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20180323A (es) | 2015-11-20 | 2018-08-06 | Idorsia Pharmaceuticals Ltd | Derivados de indol n-sustituídos como moduladores de los receptores de pge2 |
| WO2018210994A1 (en) | 2017-05-18 | 2018-11-22 | Idorsia Pharmaceuticals Ltd | Phenyl derivatives as pge2 receptor modulators |
| WO2018210992A1 (en) | 2017-05-18 | 2018-11-22 | Idorsia Pharmaceuticals Ltd | Pyrimidine derivatives |
| AU2018268311B2 (en) | 2017-05-18 | 2022-02-10 | Idorsia Pharmaceuticals Ltd | Pyrimidine derivatives as PGE2 receptor modulators |
| EP3625224B1 (en) | 2017-05-18 | 2021-08-04 | Idorsia Pharmaceuticals Ltd | N-substituted indole derivatives |
| US11325899B2 (en) | 2017-05-18 | 2022-05-10 | Idorsia Pharmaceuticals Ltd | Benzofurane and benzothiophene derivatives as PGE2 receptor modulators |
| US20200352912A1 (en) * | 2018-01-26 | 2020-11-12 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Antimicrobial compositions and methods of using the same |
| WO2019149286A1 (en) * | 2018-02-05 | 2019-08-08 | Shenzhen Ionova Life Science Co., Ltd. | Heterobicyclic carboxylic acids for treating cancer or inflammatory diseases |
| WO2020083662A1 (en) | 2018-10-23 | 2020-04-30 | Basf Se | Tricyclic pesticidal compounds |
| MX2021010323A (es) * | 2019-03-01 | 2021-12-10 | Revolution Medicines Inc | Compuestos bicíclicos de heterociclilo y usos de este. |
| CN112094249B (zh) * | 2019-06-17 | 2022-03-08 | 中国科学院苏州纳米技术与纳米仿生研究所 | 磺胺甲噻二唑-糖精共晶及其制备方法与应用 |
| MX2022005525A (es) | 2019-11-08 | 2022-06-08 | Revolution Medicines Inc | Compuestos de heteroarilo bicíclicos y usos de estos. |
| AU2021256876A1 (en) | 2020-04-14 | 2022-11-03 | Basf Se | Tricyclic pesticidal compounds |
| EP3907214A1 (en) * | 2020-05-04 | 2021-11-10 | Dompe' Farmaceutici S.P.A. | Co-crystal of ketoprofen, lysine and gabapentin, pharmaceutical compositions and their medical use |
| WO2022102731A1 (ja) | 2020-11-13 | 2022-05-19 | 小野薬品工業株式会社 | Ｅｐ４拮抗薬と免疫チェックポイント阻害物質との併用によるがん治療 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69635254T2 (de) * | 1995-07-07 | 2006-07-13 | Astrazeneca Ab | Ortho-substituierte aromatische Verbindungen, die drei (Het)aryl-Ringe enthalten, deren Herstellung und deren Verwendung als Prostaglandin-E2-(PGE2)-Antagonisten |
| ZA973884B (en) | 1996-05-23 | 1998-11-06 | Du Pont Merck Pharma | Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders |
| DE19944767A1 (de) * | 1999-09-17 | 2001-03-29 | Vasopharm Biotech Gmbh & Co Kg | N-substituierte 4-Aminopteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| AU1071301A (en) | 1999-11-01 | 2001-05-14 | Eli Lilly And Company | Pharmaceutical compounds |
| ATE527258T1 (de) | 2004-07-28 | 2011-10-15 | Takeda Pharmaceutical | Pyrroloä2,3-cüpyridinverbindung, verfahren zu deren herstellung und anwendung |
| EP1828186A1 (en) | 2004-12-13 | 2007-09-05 | Sunesis Pharmaceuticals, Inc. | Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| TW200838526A (en) * | 2006-12-01 | 2008-10-01 | Astellas Pharma Inc | Carboxylic acid derivatives |
| US8653091B2 (en) * | 2007-04-02 | 2014-02-18 | Evotec Ag | Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof |
| EP2460787A1 (en) * | 2007-07-03 | 2012-06-06 | Astellas Pharma Inc. | Amide compounds and their use as PGE2 antagonists. |
| RU2479576C9 (ru) * | 2008-05-14 | 2014-03-10 | Астеллас Фарма Инк. | Амидное соединение |
| EP2320906B1 (en) * | 2008-08-14 | 2016-02-24 | Beta Pharma Canada Inc. | Heterocyclic amide derivatives as ep4 receptor antagonists |
| WO2010027002A1 (ja) * | 2008-09-05 | 2010-03-11 | 塩野義製薬株式会社 | Ｐｉ３ｋ阻害活性を有する縮環モルホリン誘導体 |
| WO2010080864A1 (en) | 2009-01-12 | 2010-07-15 | Array Biopharma Inc. | Piperidine-containing compounds and use thereof |
| TW201103904A (en) | 2009-06-11 | 2011-02-01 | Hoffmann La Roche | Janus kinase inhibitor compounds and methods |
| SMT201700008T1 (it) | 2010-09-21 | 2017-03-08 | Eisai R&D Man Co Ltd | Composizione farmaceutica |
| WO2016021742A1 (en) | 2014-08-07 | 2016-02-11 | Takeda Pharmaceutical Company Limited | Heterocyclic compounds as ep4 receptor antagonists |
| WO2016088903A1 (en) | 2014-12-05 | 2016-06-09 | Takeda Pharmaceutical Company Limited | Heterocyclic compounds |
-
2016
- 2016-07-22 WO PCT/JP2016/072244 patent/WO2017014323A1/en not_active Ceased
- 2016-07-22 DK DK16753995.6T patent/DK3325490T3/da active
- 2016-07-22 CA CA2993312A patent/CA2993312A1/en not_active Abandoned
- 2016-07-22 EP EP16753995.6A patent/EP3325490B1/en active Active
- 2016-07-22 CN CN201680042838.4A patent/CN108368127B/zh not_active Expired - Fee Related
- 2016-07-22 JP JP2017566161A patent/JP6689297B2/ja not_active Expired - Fee Related
- 2016-07-26 US US15/746,828 patent/US10745397B2/en not_active Expired - Fee Related
-
2020
- 2020-07-06 US US16/921,338 patent/US20200339577A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017014323A1 (en) | 2017-01-26 |
| CN108368127A (zh) | 2018-08-03 |
| EP3325490A1 (en) | 2018-05-30 |
| EP3325490B1 (en) | 2019-12-18 |
| JP2018527295A (ja) | 2018-09-20 |
| US10745397B2 (en) | 2020-08-18 |
| CN108368127B (zh) | 2020-12-11 |
| JP6689297B2 (ja) | 2020-04-28 |
| US20180215754A1 (en) | 2018-08-02 |
| CA2993312A1 (en) | 2017-01-26 |
| US20200339577A1 (en) | 2020-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3325490T3 (da) | 1-substituerede 1,2,3,4-tetrahydro-1,7-naphthyridin-8-aminderivater og deres anvendelse som ep4-receptorantagonister | |
| NO2023013I1 (no) | Combination of foslevodopa and foscarbidopa, each in all forms protected by the basic patent | |
| IL266472A (en) | Indazole derivatives as alpha-v-integrin antagonists | |
| IL258081B (en) | Benzimidazole history and their use | |
| IL254124A0 (en) | New 3-indole-transformed histories, medicinal preparations and methods of use | |
| DK3302448T3 (da) | Erstattede heterocyclylafledninger som cdk-inhibitore | |
| DK3490565T3 (da) | Azetidinderivater som chemokinreceptormodulatorer og anvendelser deraf | |
| DK3355884T3 (da) | Tetrahydro-1h-pyrido[3,4-b]indol-antiøstrogenlægemidler | |
| HUE058009T2 (hu) | 1,3-Tiazol-2-il szubsztituált benzamid-származékok | |
| DK3328849T3 (da) | 1,1,1-trifluor-3-hydroxypropan-2-yl-carbamat-derivater og 1,1,1-trifluor-4-hydroxybutan-2-yl-carbamat-derivater som magl-inhibitorer | |
| DK3121175T3 (da) | 1,3-benzodioxolderivater som ezh1- og/eller ezh2-hæmmere | |
| DK3271349T3 (da) | Benzimidazolederivater som bromodomain-inhibitorer | |
| DK3288940T5 (da) | Azabenzimidazoler og deres anvendelse som ampa-receptormodulatorer | |
| DK3137168T3 (da) | Substituerede 4-phenylpiperidiner, deres fremstilling og anvendelse | |
| LT3319963T (lt) | Pakeistieji 4-azaindolai ir jų, kaip glun2b receptoriaus moduliatorių, panaudojimas | |
| DK3672951T3 (da) | Quinoxalinderivater som adenosinreceptorantagonister | |
| DK3287443T3 (da) | 6-leddet heterocyklisk derivat og farmaceutisk sammensætning, som omfatter dette | |
| SG11202001337XA (en) | Bezimidazole derivatives as adenosine receptor antagonists | |
| DK3347356T3 (da) | Tricyclic forbundet pyridin-2-one-derivater og deres anvendelse som brd4-hæmmere | |
| BR112016026552A2 (pt) | derivados de carboxamida, seus usos, composição farmacêutica, e combinação | |
| DK3196194T3 (da) | Pyrimidinderivater, der er nyttige som selektive jak3- og/eller jak1-inhibitorer | |
| IL261643B (en) | Piperidine derivatives, their preparation and use | |
| DK3487851T3 (da) | Aminopyridinderivater og deres anvendelse som selektive alk-2-inhibitorer | |
| ZA201704462B (en) | New benzimidazole derivatives as antihistamine agents | |
| BR112016027383A2 (pt) | Derivados de naftiridinadiona, seus usos, composição farmacêutica e combinação |